Form 4 for BDX Becton Dickinson
Accepted 2022-08-17 00:00:00 ET · period of report 2022-08-15 · accession 0001062993-22-018159 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-08-17 | 2022-08-15 | BDX | Hickey David | EVP, Pres, Life Sciences | S - Sale | $265.00 | -475 | 3,331 | -12% | -$125.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-08-15 | S | D | 475 | $265.00 | 3,331 | D | — | — | (F1) Direct holdings reflect adjustments made in connection with the spin-off of Embecta Corp. to the number of shares underlying previously reported and unvested time-vested restricted stock units held by the reporting person. This transaction was made pursuant to a 10b5-1 plan entered into on March 9, 2022. |